Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 21.18% of VIRX shares are held by financial institutions. is the top corporate investor, holding 0 shares valued at -. A 0% stake in Viracta Therapeutics, Inc. is owned by the company. JANE STREET GROUP, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the VIRX insiders holding of 2.99% of the stake in company, AISLING CAPITAL IV, LP, 10 percent owner, holds the largest shares of 10.1M. BAY CITY CAPITAL LLC, 10 percent owner, is the second largest VIRX insider with ownership of 5.27M shares. SANDELL SCOTT D, 10 percent owner, stands third with possession of 4.66M shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| AISLING CAPITAL IV, LP | 10 percent owner | 10.1M |
| BAY CITY CAPITAL LLC | 10 percent owner | 5.27M |
| SANDELL SCOTT D | 10 percent owner | 4.66M |
| BARRETT M JAMES | 10 percent owner | 4.66M |
| BARRIS PETER J | 10 percent owner | 4.66M |
| BASKETT FOREST | 10 percent owner | 4.66M |
| GROWTH EQUITY OPPORTUNITIES FUND, LLC | 10 percent owner | 4.66M |
| KERINS PATRICK J | 10 percent owner | 4.66M |
| DRANT RYAN D | 10 percent owner | 4.66M |
| KOLLURI KRISHNA KITTU | 10 percent owner | 4.66M |
| MPM ONCOLOGY IMPACT MANAGEMENT GP LLC | 10 percent owner | 3.33M |
| ROYSTON IVOR | CEO & President | 612.77K |
| SWISHER DANIEL N JR | President and CEO | 199.74K |
| QUINN WILLIAM P. | See Remarks | 127.7K |
| CHEVALLARD DANIEL R. | CFO and COO | 102.31K |
| ROTHERA MARK | President and CEO | 100K |
| KETCHUM STEVEN B | director | 80.83K |
| BJERKHOLT ERIC | EVP, CFO & Corp. Secretary | 80.4K |
| PARKER GEOFFREY M. | director | 65.75K |
| ROJKJAER LISA | Chief Medical Officer | 48.09K |
| GULLOTTA TINA | VP, Finance | 20.5K |
| CRAIG ADAM R | EVP, Development & CMO | 12.72K |
| MISFELDT DAYTON | director | 3.74K |
